Enacted — Signed by the President — Jun 29, 2015
Last Action: Signed by President.
Explanation: This bill was enacted after being signed by the President on June 29, 2015.
May 23, 2005
109th Congress, 2005–2006
Enacted — Signed by the President on Dec 20, 2005
This bill was enacted after being signed by the President on December 20, 2005.
Representative for New Jersey's 4th congressional district
Read Text »
Last Updated: Dec 19, 2005
Length: 14 pages
To provide for the collection and maintenance of human cord blood stem cells for the treatment of patients and research, and to amend the Public Health Service Act to authorize the C.W. Bill Young Cell Transplantation Program.
Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.
Reported by Committee
Last Action: Jun 29, 2005
The “H.R.” in “H.R. 2520” means this is a House of Representatives bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The committee chair determines whether a bill will move past the committee stage.
Search for similar bills.
Click a format for a citation suggestion:
Civic Impulse. (2015). H.R. 2520 — 109th Congress: Stem Cell Therapeutic and Research Act of 2005. Retrieved from https://www.govtrack.us/congress/bills/109/hr2520
“H.R. 2520 — 109th Congress: Stem Cell Therapeutic and Research Act of 2005.” www.GovTrack.us. 2005. June 30, 2015 <https://www.govtrack.us/congress/bills/109/hr2520>
|title=H.R. 2520 (109th)
|accessdate=June 30, 2015
|author=109th Congress (2005)
|date=May 23, 2005
|quote=Stem Cell Therapeutic and Research Act of 2005